Management of upper limb dysfunction in children with cerebral palsy: a systematic review

Boyd, R. N., Morris, M. E. and Graham, H. K. (2001). Management of upper limb dysfunction in children with cerebral palsy: a systematic review. In: Meeting on Clinical Considerations for the Therapeutic Use of Botulinum Toxin Type-A in Cerebral Palsy: an Evidence-Based Examination, Lake Maggiore, Italy, (150-166). June 2000. doi:10.1046/j.1468-1331.2001.00048.x


Author Boyd, R. N.
Morris, M. E.
Graham, H. K.
Title of paper Management of upper limb dysfunction in children with cerebral palsy: a systematic review
Conference name Meeting on Clinical Considerations for the Therapeutic Use of Botulinum Toxin Type-A in Cerebral Palsy: an Evidence-Based Examination
Conference location Lake Maggiore, Italy
Conference dates June 2000
Journal name European Journal of Neurology   Check publisher's open access policy
Place of Publication Oxford, United Kingdom
Publisher Wiley-Blackwell
Publication Year 2001
Sub-type Fully published paper
DOI 10.1046/j.1468-1331.2001.00048.x
ISSN 1351-5101
1468-1331
Volume 8
Issue Supplement 5
Start page 150
End page 166
Total pages 16
Language eng
Abstract/Summary Effective use of the upper limb can impact on educational outcomes, participation in activities of daily living and vocational options for many children with cerebral palsy (CP). This article presents the results of a systematic review of the literature on the management of upper limb dysfunction in children with CP. The range of management options includes therapies such as physiotherapy, occupational therapy, neurodevelopmental therapy and conductive education; peripheral splinting and casting; focal or generalized pharmacotherapy; and surgery to improve upper limb function or correct deformity. A literature search identified 60 papers, of which four were randomized controlled trials and 44 were prospective studies with objective outcome measures. Principal studies undertaken for each type of treatment and the efficacy of the different types of treatment were critically evaluated. In addition, the current level of evidence for each study was evaluated according to Sackett’s (1989) model and ICIDH-2 classification. A close examination of two relatively new treatments for upper limb spasticity, constraint induced movement therapy and botulinum toxin type A (BTX-A) was conducted with reference to more extensive data on the efficacy of BTX-A in the lower limb.
Keyword Botulinum toxin type A
Cerebral palsy
Constraint induced movement therapy
Movement disorders
Physical therapy
Systematic review
Upper limb
Q-Index Code E1
Q-Index Status Provisional Code
Institutional Status Non-UQ

Document type: Conference Paper
Collection: School of Medicine Publications
 
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 113 times in Thomson Reuters Web of Science Article | Citations
Google Scholar Search Google Scholar
Created: Thu, 10 Mar 2011, 20:15:37 EST